Mohamad Cherry
About Mohamad Cherry
Mohamad Cherry serves as the Medical Director of Hematology/Oncology at Atlantic Health System in Morristown, NJ. He has a robust background in clinical research, focusing on new therapeutics for blood cancers and has published extensively in the field.
Work at Atlantic Health System
Mohamad Cherry serves as the Medical Director of Hematology/Oncology at Atlantic Health System in Morristown, NJ. He has held this position since 2017, contributing to the advancement of treatment options for patients with blood cancers. His role involves overseeing clinical operations and leading research initiatives aimed at improving patient outcomes in hematology and oncology.
Education and Expertise
Mohamad Cherry has an extensive educational background in medicine and research. He earned his Doctor of Medicine (MD) from Lebanese University, followed by a residency in Internal Medicine at Staten Island University Hospital. He completed his fellowship in Hematology Oncology at the University of Oklahoma, where he later served as Program Director for the Hematology Oncology Fellowship. He also holds a Master's degree in Clinical and Translational Research from the University of Oklahoma, enhancing his expertise in developing new therapeutics.
Research Contributions
As a principal investigator, Mohamad Cherry has performed groundbreaking research in the development of new therapeutics for relapsed and refractory blood cancers. He has led multiple clinical trials, including Phase I, II, and III studies funded by the National Cancer Institute and pharmaceutical companies. His research focuses on epigenetics as biomarkers for chemotherapy response in osteosarcoma and he actively participates in clinical trials for various blood cancers.
Professional Affiliations and Leadership
Mohamad Cherry has held significant leadership roles in the field of hematology and oncology. He co-chaired the Leukemia Working Group at the Sarah Cannon Research Institute Blood Cancer Consortium and was selected as a Hematology Advocate by the ASH Advocacy Leadership Institute in 2015. His involvement in professional organizations underscores his commitment to advancing the field and advocating for patients.
Publications and Presentations
Mohamad Cherry has published over 20 peer-reviewed papers in leading scientific journals, contributing to the body of knowledge in hematology and oncology. He has presented his research at major hematology and oncology meetings, including those sponsored by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO), showcasing his findings to the broader medical community.